TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07379684: A Study of Amicidin-β Topical Solution for Patients With Surgical or Traumatic Wound Infections

Sponsor: Macro Biologics, Inc. · Phase: PHASE1 · Area: INFECTIOUS_VACCINE · Target Enrollment: 44 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$539,784

Rescue Site Savings

+$359,856

Unlock Full NCT07379684 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07379684 Rescue Dossier →